NCT02169284: A trial that was reported late by National Cancer Institute (NCI)
This trial has reported, although it was 307 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02169284 |
|---|---|
| Title | Phase II Clinical Chemoprevention Trial of Weekly Erlotinib Before Bladder Cancer Surgery |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 1, 2014 |
| Completion date | March 30, 2018 |
| Required reporting date | March 30, 2019, midnight |
| Actual reporting date | Jan. 31, 2020 |
| Date last checked at ClinicalTrials.gov | June 15, 2026 |
| Days late | 307 |